Regulatory News
Friday, June 24, 2016
BRIEF-Paion, unit of Cosmo Pharmaceuticals enter into license deal for Remimazolam
* Co and Cosmo Technologies Ltd, unit of Cosmo
Pharmaceuticals NV, entered into license agreement for
Remimazolam
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment